Introduction: Private label and OEM sunscreen models split responsibility for formula ownership, label claims, sample approval, and version control in different ways.
A new brand team usually arrives at sunscreen with a formula idea, a launch window, and a supplier shortlist, then discovers that the supply model quietly decides who is answerable for what. In one model the brand picks a standing formula and builds an identity around it. In the other, the formula itself is built around the brand's brief. The difference is not about which factory is friendlier or which quote looks smaller. It is about who owns the formula record, who writes and signs the label, what a sample signature actually freezes, and who tracks versions when something changes. This comparison walks through those handover points so a first-time team can read a proposal and understand what it is agreeing to.
In private label work, the sunscreen base already exists. A private label sunscreen manufacturer keeps a set of standing formulas — a tinted mineral lotion, a lightweight serum, a primer-style base — and the brand's job is to choose among them, then build the market identity around that choice. The brand owns the positioning, the shade story, the pack format, the retail price band, and the wording on the front and back of the carton. That sounds like the lighter path, and in many ways it is, because the technical work of stabilizing an emulsion and running it on a filling line has already happened before the brand enters the conversation. What does not move is the label. FDA guidance on sunscreen labeling and effectiveness testing describes the Drug Facts panel, SPF statements, and tested claims as part of the marketed product's label, and the name printed on that label is the party a buyer or regulator looks for. A brand can buy a finished base and still own every word printed on it. The same logic runs through advertising: FTC guidance on endorsements and advertising places responsibility for truthful, substantiated claims on the advertiser. A private label brand that prints "reef safe" or "all-day protection" on a carton it did not formulate is still the party that has to support those words if anyone asks. That is the cleanest way to picture private label: the formula comes in as a product, the label goes out as the brand's own promise.
OEM moves the starting point. Instead of choosing from a shelf, the brand brings a brief — texture, finish, tint depth, filter direction, pack format — and an OEM sunscreen manufacturer builds or adapts a base to answer it. The formula becomes a project deliverable rather than a catalogue item, and that shift changes who holds the technical record. The maker typically owns the bench work, the stability runs, the scale-up trials, and the internal document that states which version was produced on which date. The brand owns the brief, the acceptance criteria, and the final approval. Splitting it any other way creates the classic first-launch problem: a brand that cannot say which formula version it actually approved. Version control is where this split earns its keep. On a standing private label base, version numbers move rarely and usually only when the supplier reformulates. In OEM work the formula may shift several times between the first bench sample and the production run, and each shift needs its own identifier so that a comment about "the second sample" means the same thing on both sides of the conversation. A tinted base shows why this matters, because colour and texture drift together. The Lanthome concept prototype offered as Liquid Zinc SPF 30 Tinted Sunscreen (model PS88-SP) illustrates the shape of such a project: a broad-spectrum SPF 30 label claim, a tinted Orange tone, and 30 ml, 60 ml, and 150 ml fills. Treating that base as a starting point to adapt, or as a finished look to license, changes who signs off on each revision. Any sunscreen lotion manufacturer working in OEM mode will normally separate the development record from the brand's approval record for exactly this reason.
Sample approval looks like the same step in both models — a box arrives, someone tries it, someone says yes — but the meaning of that yes is different. In private label the sample confirms that a standing base matches its description. In OEM the sample freezes a formula version. Label responsibility splits along a similar line: the maker may print, translate, and execute artwork, while the brand stays the owner of the copy.
In private label work the sample round is mostly a matching exercise. The brand checks tint, glide, finish, and how the base behaves under makeup against the description it was given, then accepts it or asks about an existing alternative. Sign-off is quick because nothing new was created for that brand. In OEM work the same signature carries more weight: it converts a development sample into the reference version that production will be measured against later. That is why model contract concepts from bodies such as the ICC treat sample sign-off and quality clauses as linked ideas — a signed sample is the physical definition of what "conforming" means for every batch that follows.
Labels are usually produced by the factory or a nominated printer, which makes it easy to assume the factory also owns the wording. Ownership of the copy stays with the brand, which writes the claims, approves the ingredient list, and confirms the shade name while the maker executes artwork and applies it to the pack. Keeping a dated copy of the approved artwork on both sides is the simple habit that stops a batch being printed from an old file.
The practical difference between private label and OEM sunscreen models comes down to four questions: who owns the formula record, who writes the label copy, what a signed sample freezes, and how versions are numbered. A brand team that can answer those four for itself can read a proposal quickly, because the supply model stops being a vague category and becomes a set of named responsibilities. Neither route is better in general. A standing base suits a fast first launch, and a developed formula suits a brand that needs a specific feel or shade. Knowing which one is on the table is the part that shapes everything after it. Readers who want to see how a tinted mineral concept is presented can look over the Lanthome Skincare product details and compare them with the responsibilities described above.
A: Private label starts from a formula that already exists, so the brand selects a standing base and builds its identity around it. OEM starts from a brief and builds or adapts a formula to match it. The main difference sits in formula ownership and development records: in private label the maker holds the standing formula and the brand holds the label, while in OEM the maker holds a development record tied to one brand's brief and the brand holds the approval.
A: The manufacturer or formula provider controls the standing formula and its documentation. The brand chooses among available bases and, in semi-custom arrangements, may request adjustments to scent, texture, or packaging, but the core formula and its version history stay with the supplier. The brand controls how that base is named, positioned, and described on the label.
A: In private label, sample approval confirms that a standing base matches expectations, so the decision is fast and rarely changes production. In OEM, the same signature locks a specific formula version that later batches are measured against, which is why development records and version numbers matter more. Label responsibility differs for a related reason: the maker often prints and applies artwork, yet the brand owns the claims, because the marketed product's label carries the brand's name and promises.
FTC's Endorsement Guides: What People Are Asking
ICC Model Contracts and Clauses
Liquid Zinc SPF 30 Tinted Sunscreen – Private Label Concept Prototype